Focus Partners Wealth
MIST icon

Focus Partners Wealth’s Milestone Pharmaceuticals MIST Stock Holding History

Focus Partners Wealth’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.8K Hold
36,000
– – ﹤0.01% 2587
2025
Q4 		$72.7K Hold
36,000
– – ﹤0.01% 2581
2025
Q3 		$72K Hold
36,000
– – ﹤0.01% 2147
2025
Q2 		$69.8K Buy
+36,000
New +$48K ﹤0.01% 1963

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Focus Partners Wealth's MIST Position: Q1 2026 in Review

Focus Partners Wealth held its Milestone Pharmaceuticals (MIST) position steady in Q1 2026 at 36,000 shares worth $42.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2587.

Focus Partners Wealth first reported a position in MIST in Q2 2025 and has held it in 4 quarters since. The position peaked at $72.7K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Focus Partners Wealth held 36,000 shares of Milestone Pharmaceuticals worth $42.8K as of Q1 2026.
  • Focus Partners Wealth left its Milestone Pharmaceuticals share count unchanged in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2587 holding.
  • Focus Partners Wealth first reported a position in Milestone Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Focus Partners Wealth's Milestone Pharmaceuticals position peaked at $72.7K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.